Alterations in bovine platelet function and acute phase proteins induced by Pasteurella haemolytica A1.
Platelet function was assessed by aggregometry in 10 Holstein calves before and after exposure to Pasteurella haemolytica (biotype A, serotype 1) by intrabronchial challenge. At 24 h after exposure the platelets had become more reactive to stimulation with known platelet agonists such as adenosine diphosphate (ADP) and platelet-activating factor (PAF) and the platelet aggregates that formed were more resistant to disaggregation. The activation of platelets was an early response in the challenged calves as platelet function had returned to pretreatment levels 72 h after exposure to the bacteria while the acute phase reactant proteins, haptoglobin and fibrinogen, were approaching their peak values and alpha 2-macroglobulin levels had also risen significantly (P < 0.05) at this time. The plasma levels of these proteins were still elevated and albumin levels were depressed 6 d post-treatment. At post-mortem all calves exhibited pneumonic tissue damage. When P. haemolytica leukotoxin was added directly to bovine platelet suspensions both spontaneous aggregation and an increase in the aggregation response to ADP and PAF stimulation were observed. The morphological appearance of the platelet aggregates exhibited the typical pattern for bovine platelets with 2 distinct zones of cells being visible within each aggregate. One zone contained platelets in which the cytoplasmic granules were still evident and the other zone contained irregularly shaped platelets devoid of granular content. In the latter zone, discrete gaps, or pores, were evident in the plasma membrane of numerous platelets. This pore formation is characteristic of leukotoxin action and is not observed in ADP or PAF induced aggregates.
Cheryk
L A
LA
Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph.
Hooper-McGrevy
K E
KE
Gentry
P A
PA
D000209:Acute-Phase Proteins / Q000096:biosynthesis*; D000818:Animals; D001427:Bacterial Toxins / Q000633:toxicity; D001792:Blood Platelets / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D002417:Cattle; D002418:Cattle Diseases; D005098:Exotoxins / Q000633:toxicity; D005340:Fibrinogen / Q000096:biosynthesis; D006242:Haptoglobins / Q000096:biosynthesis; D066298:In Vitro Techniques; D008297:Male; D016978:Mannheimia haemolytica / Q000145:classification; D008854:Microscopy, Electron; D010326:Pasteurella Infections / Q000097:blood / Q000662:veterinary*; D010974:Platelet Aggregation; D010979:Platelet Function Tests / Q000379:methods / Q000662:veterinary; D012703:Serotyping; D013997:Time Factors; D000511:alpha-Macroglobulins / Q000096:biosynthesis
D000209:Acute-Phase Proteins; D001427:Bacterial Toxins; D005098:Exotoxins; D006242:Haptoglobins; D000511:alpha-Macroglobulins; C018579:leukotoxin; D005340:Fibrinogen